Literature DB >> 8086311

Towards an understanding of Wilms' tumour.

K A Williamson1, V Van Heyningen.   

Abstract

Many areas of research are contributing to our understanding of WT and the role of WT1 in development of the renal and genitourinary systems. Characterization of putative target genes and the control of their expression continues. The importance of isoform ratios and imprinting effects are also under active investigation, often using animal models. The accumulating mutation data, together with evolutionary studies, illuminate WT1 structure-function relationships, highlighting the regions critical in normal development and tumorigenesis. And last, but by no means least, the hunt for the WT2 and WT3 genes continues.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8086311      PMCID: PMC2001799     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  84 in total

Review 1.  Functional inactivation of genes by dominant negative mutations.

Authors:  I Herskowitz
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

2.  WT-1 is required for early kidney development.

Authors:  J A Kreidberg; H Sariola; J M Loring; M Maeda; J Pelletier; D Housman; R Jaenisch
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

3.  Two anonymous DNA segments distinguish the Wilms' tumor and aniridia loci.

Authors:  L M Davis; R Stallard; G H Thomas; P Couillin; C Junien; N J Nowak; T B Shows
Journal:  Science       Date:  1988-08-12       Impact factor: 47.728

4.  Pericentric intrachromosomal insertion responsible for recurrence of del(11)(p13p14) in a family.

Authors:  I Henry; J Hoovers; F Barichard; M F Berthéas; A Puech; F Prieur; M Gessler; G Bruns; M Mannens; C Junien
Journal:  Genes Chromosomes Cancer       Date:  1993-05       Impact factor: 5.006

5.  Homozygous inactivation of WT1 in a Wilms' tumor associated with the WAGR syndrome.

Authors:  M Gessler; A König; J Moore; S Qualman; K Arden; W Cavenee; G Bruns
Journal:  Genes Chromosomes Cancer       Date:  1993-07       Impact factor: 5.006

6.  Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product.

Authors:  H Werner; G G Re; I A Drummond; V P Sukhatme; F J Rauscher; D A Sens; A J Garvin; D LeRoith; C T Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

7.  Nonrandom loss of maternal chromosome 11 alleles in Wilms tumors.

Authors:  W T Schroeder; L Y Chao; D D Dao; L C Strong; S Pathak; V Riccardi; W H Lewis; G F Saunders
Journal:  Am J Hum Genet       Date:  1987-05       Impact factor: 11.025

8.  Age distribution of Wilms' tumor: report from the National Wilms' Tumor Study.

Authors:  N Breslow; J B Beckwith; M Ciol; K Sharples
Journal:  Cancer Res       Date:  1988-03-15       Impact factor: 12.701

9.  Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues.

Authors:  J Scott; J Cowell; M E Robertson; L M Priestley; R Wadey; B Hopkins; J Pritchard; G I Bell; L B Rall; C F Graham
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

10.  A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization.

Authors:  V P Sukhatme; X M Cao; L C Chang; C H Tsai-Morris; D Stamenkovich; P C Ferreira; D R Cohen; S A Edwards; T B Shows; T Curran
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.